Topo2α protein expression predicts response to anthracycline combination neo-adjuvant chemotherapy in locally advanced primary breast cancer

BACKGROUND: This study aimed to identify predictors of response to anthracycline-based chemotherapy (5-fluoro-uracil, epirubicin, cyclophosphamide (FEC)) in locally advanced primary breast cancer (LAPC). METHODS: A total of 91 LAPC patients were treated with six cycles of FEC before surgery. Protein...

Descripción completa

Detalles Bibliográficos
Autores principales: Mukherjee, A, Shehata, M, Moseley, P, Rakha, E, Ellis, I, Chan, S
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2010
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3008601/
https://www.ncbi.nlm.nih.gov/pubmed/21063406
http://dx.doi.org/10.1038/sj.bjc.6605960

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3008601/
https://www.ncbi.nlm.nih.gov/pubmed/21063406
http://dx.doi.org/10.1038/sj.bjc.6605960

Ejemplares similares